Explain this page
Arphra AIPlain-English read on Qiagen N.V.’s valuation06-04today
- Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcript2d
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use2d
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma3d
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma3d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $45.17 (+23.48%)
Candlestick · 1Y
Open in chart workstation →QGEN
37.01-29.07%H 53.30L 32.53MA50 38.40MA200 —Avg vol 2.1M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.72% | -1.05% | +10.92% | -11.94% | -23.14% | -22.73% | -21.42% | -21.18% | -22.35% | +69.67% | +1747.47% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$36.58
1,527 sh
Bid
$34.22
100 sh
Ask
$40.00
100 sh
Spread
$5.780
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
Top industries (issuer's industry highlighted)
- Medical - Diagnostics & Research+0.45%
- Department Stores-6.26%
- Consulting Services-4.82%
- Education & Training Services-3.71%
- Medical - Equipment & Services+3.71%
- Solar-3.63%
- Electronic Gaming & Multimedia+3.56%
- Software - Application-3.50%
- Grocery Stores-3.45%
- Discount Stores-3.44%
- Other Precious Metals-3.35%
- Steel-3.33%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcriptseekingalpha.com·Jun 15, 2026
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Usezacks.com·Jun 15, 2026
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharmabusinesswire.com·Jun 15, 2026
- QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharmabusinesswire.com·Jun 15, 2026
- A Look at Qiagen NV (QGEN) After 4.2% Gain -- GF Value $52.66 vs Price $37.75gurufocus.com·Jun 09, 2026
- Qiagen (QGEN) Up 12.1% Since Last Earnings Report: Can It Continue?zacks.com·Jun 05, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGENprnewswire.com·Jun 04, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGENprnewswire.com·Jun 04, 2026
Peers
No peer list available for QGEN.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|